Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAO | P14920 | 4/20 | 1.00 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.43 |
| ▸ | TCF7L2 | Q9NQB0 | 1/20 | 0.43 |
| ▸ | PARP1 | P09874 | 1/20 | 0.43 |
| ▸ | AHR | P35869 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TTR | P02766 | 1/20 | 0.40 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.39 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.39 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.39 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.39 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.39 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.39 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL481873 | 0.84 | DAO (0.72) | DAOPARP1AHR | |
| SCHEMBL1100359 | 0.76 | DAO (0.61) | DAOCTNNB1TCF7L2PARP1ALDH1A1 | |
| SCHEMBL9411282 | 0.76 | DAO (0.61) | DAOCTNNB1TCF7L2PARP1ALDH1A1 | |
| SCHEMBL3526289 | 0.76 | DAO (0.61) | DAOCTNNB1TCF7L2 | |
| SCHEMBL482156 | 0.76 | DAO (0.61) | DAOAHRALDH1A1TTRGRIN2D | |
| SCHEMBL8116280 | 0.76 | DAO (0.61) | DAOCTNNB1TCF7L2ALDH1A1 | |
| SCHEMBL30182741 | 0.76 | DAO (0.61) | DAOCTNNB1TCF7L2PARP1 | |
| SCHEMBL11130742 | 0.76 | DAO (0.61) | DAOALDH1A1 | |
| SCHEMBL22227188 | 0.76 | DAO (0.61) | DAOCTNNB1TCF7L2PARP1 | |
| SCHEMBL1071182 | 0.73 | DAO (0.58) | DAOPARP1AHRTTRGRIN2D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 381 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119940783-A | Design method for enhancing flexibility of low-carbon building energy and interactive friendliness of power grid | 中建壹品投资发展有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-119809026-A | Multi-path optimization method and device for carbon emission reduction in electricity utilization area | 国网河北省电力有限公司综合服务中心 | 2025-04-11 | — | — | CN | claimed |
| CN-119378824-A | Life-cycle-based carbon emission accounting method for household garbage fine utilization system | 华中科技大学 | 2025-01-28 | — | — | CN | claimed |
| CN-119180438-A | Data-driven optical-biogas virtual power plant two-stage low-carbon scheduling method and system | 国网江苏省电力有限公司连云港供电分公司 | 2024-12-24 | — | — | CN | claimed |
| US-20240368659-A1 | MICROBIAL CELL FACTORIES PRODUCING VITAMIN B COMPOUNDS | BIOSYNTIA APS (DK) | 2024-11-07 | — | — | US | claimed |
| CN-118551599-A | Multi-field coupling operator splitting solving method and equipment for biological plugging well flow model | 广州地铁设计研究院股份有限公司 | 2024-08-27 | — | — | CN | claimed |
| CN-118095535-A | Multi-energy coupling system based on cofiring technology and optimal configuration method thereof | 南昌大学 | 2024-05-28 | — | — | CN | claimed |
| EP-4370653-A2 | MICROBIAL CELL FACTORIES PRODUCING VITAMIN B COMPOUNDS | Biosyntia ApS (DK) | 2024-05-22 | — | — | EP | claimed |
| CN-117937541-A | Rural comprehensive energy system under light and biogas cooperation and optimal operation method | 中国矿业大学 | 2024-04-26 | — | — | CN | claimed |
| US-20240016772-A1 | Compositions And Methods Comprising D-Cysteine Or A D-Derivative Thereof | UNIVERSITE DE GENEVE (CH) | 2024-01-18 | — | — | US | claimed |
| US-11872492-B2 | Color blindness diagnostic system | ELECTRONIC ARTS INC. (US) | 2024-01-16 | — | — | US | claimed |
| EP-4203938-A1 | COMPOSITIONS AND METHODS COMPRISING D-CYSTEINE OR A D-DERIVATIVE THEREOF | Université de Genève (CH) | 2023-07-05 | — | — | EP | claimed |
| US-20230146141-A1 | COLOR BLINDNESS DIAGNOSTIC SYSTEM | ELECTRONIC ARTS INC. | 2023-05-11 | — | — | US | claimed |
| WO-2023285585-A2 | MICROBIAL CELL FACTORIES PRODUCING VITAMIN B COMPOUNDS | BIOSYNTIA APS (DK) | 2023-01-19 | — | — | WO | claimed |
| US-20220127311-A1 | CELL FACTORIES FOR IMPROVED PRODUCTION OF COMPOUNDS AND PROTEINS DEPENDENT ON IRON SULFUR CLUSTERS | BIOSYNTIA APS (DK) | 2022-04-28 | — | — | US | claimed |
| WO-2022043265-A1 | COMPOSITIONS AND METHODS COMPRISING D-CYSTEINE OR A D-DERIVATIVE THEREOF | UNIVERSITÉ DE GENÈVE (CH) | 2022-03-03 | — | — | WO | claimed |
| EP-3960168-A1 | COMPOSITIONS AND METHODS COMPRISING D-CYSTEINE OR A DERIVATIVE THEREOF | Université de Genève (CH) | 2022-03-02 | — | — | EP | claimed |
| CN-110389938-B | Method for improving safety of relay protection equipment | 北京四方继保自动化股份有限公司 | 2022-02-22 | — | — | CN | claimed |
| US-12636287-B2 | Organic compounds | INTRA-CELLULAR THERAPIES, INC. (US) | 2026-05-26 | — | — | US | disclosed |
| US-20070049556-A1 | NOVEL BENZOPYRAN DERIVATIVES AS POTASSIUM CHANNEL OPENERS | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070049556-A1 | NOVEL BENZOPYRAN DERIVATIVES AS POTASSIUM CHANNEL OPENERS | KCNJ2, KCNN1, KCNN3 | DAO 4140/4885CTNNB1 1778/4885TCF7L2 2659/4885 |
| US-12636287-B2 | Organic compounds | PDE1A, PDE1B, PDE5A | DAO 834/4885CTNNB1 444/4885TCF7L2 1886/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.